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1. [tttrodttction 
Delineation of  corticosteroid hormone action is 
not only one of  the few means available to understand 
the organisation and expression o f  the complex 
mammalian genome but it also provides important 
cues for current therapy in a wide varieW of  clinical 
disorders. The accepted sequence o f  events is ~ased 
around the concept where ~he steroid ligand bound 
to its cytoplasmic arrier moves into the nucleus and 
associates itself with the accepter sites in the target. 
The present paper is l imited to a review o f  current 
l iterature on physical characterisat~on of  the cytosol  
vector specific for the ~uco-  and the mineralocorti- 
c0ids. 17his excludes detaited consideratiort o f  other 
steroid binders (viz., albumin, !igandin, transcortin) 
as welt as of  receptors for other classes o f  hormones 
(estradiol, progesterone, testeosterone) although they 
have been taken into consideration when rdevant.  
Since a current research on MedRar revealed more than 
300 papers during the three preceding years, reference 
is most often made to a number  of  existing reviews 
[1-31 and books [4,51, where possible for both 
~uco-  [1,4,5] and mineralo- [2--5] groups of  
hormones. Literature citation is not meant to estab- 
lish priorities but to lead the reader to an appropriate 
departing point for further thought.  
2. Technical considerations 
A currently accepted sequence of  eventa in the 
mechanism of  corticoid hormone action consists of  
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tile entry of  the tipephi~ic steroid motecute into the 
cell cytoplasm with subsequent binding to specific 
high affinity (K d t0 -l° or clcse to it), low capacity 
(therefore saturabie) receptoJs. This complex is there- 
after 'activated' by a number o f  factors (temperature,  
ionic strength), presumably hi the cytoplasm. The 
activated eom~iex is finaI'y s ~id to penetrate the 
nuclear membrane and to int_*ract with the accepter 
sites in the chromatin and/or DNA as a prerequisite 
for modu!at ien of  the organ ::peciflc response. The 
role of high capacity (thus nonsaturable), low aff inity 
(K d approx, t0 -9) serum binders (transcortin, 
Nbumin) is not clear in this sequence o f  events (dis- 
cussed later). Thus, a receptor is the immediate 
requirement for t~ssue response whereas a bi0..der is 
art agent capable of  transporting the ligand but not 
necessar~y of eliciting the desired reaction_ 
Since the concept of  a receptor, by definition, pre- 
supposes the presep~e f  a macromotecule within any 
given targe ~ ear~k, le of  responding to a specific externM 
stimulus b-" ~_.mely, sequential and orderly Mteration 
in a gror.p of processes, a speculative presumption 
explaired corticoid response as a 'one hiC type o f  
mechanism where possibly only one single site may 
be involved for all grades of  agonist and antagonist 
activity, depending upon the affinity of  the ligand 
for its vector. The ease and rapidity of  Scatchard type 
of  analysis fv.rther channelled all expertmentai effort 
towards the eluci~,ation of  a receptor a priof~ con- 
sidered homogeneous and unitary by the very nature 
of  definitiom More recent comparative work with 
various techniques based on saturation and compet i t ion 
has revealed iscrepancies in the interpretation o f  
resAts obtained with equil ibrium binding, especiai!y 
since the latter must be disturbed by the addition o f  
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charcoal prior to est imation o f  saturation characterstics. 
Physical separation and purif ication, thus, were 
clearly needed to establish ".he nature o f  the receptor 
and it is to this aspect the sections below are addressed. 
3. Glucocorticoid receptor 
Density gradient centrifugation has been one of  
the earliest and the most time honoured tools avail- 
able to the molecular biologist. Application of  this 
method to receptor separation was beset with two 
major diffict~ities. First, lengthy centrifugation periods 
resulted in dissociation o f  the bound tigand although 
synthetic steroid (tr iamcino]one, dexamethasone) 
receptor complexes [8] could withstand dissociation 
more readily than natural s tero id - receptor  com- 
plexes [9--1 ! ].  Second, this procedure is based upon 
separation by sedimentation coefficients o f  the 
macromolecute varying in S vdues between 3 S for 
the thymocyte receptor [8] to 5.5 S in the fibroblast 
[ 12] and does not permit resolution o f  act':vated 
versus inactive fom~s o f  the receptor. Association into 
larger 7 -8  S forms in presence of  low salt, and their 
d issoc ia t ion  in to  snaal!er 4 S un i ts  w i th  h igh  salt  
buffers could however be achieved in the lung with 
density gradient cent_rifugation [ 13 ]. Fractions o f  
smaller molecular weight, Stoke's radius and sedimenta- 
tion coefficients were observed under conditions that 
favoured proteolyt ic leavage in rat liver cytosol [ 14]. 
Among numerous gels, Sephadex beads o f  graded 
sizes were the first available to the biochemist.  With 
this technique of  molecular wei~_t filtration, a 
monomer  approx,  moI.  wt 67 000 was estimated for 
rat liver cytosol binder [15--17] which could poly- 
merise into complexes of  higher molecular weight 
reaching as high as 200 000 for rat liver [9--1 I] and 
600 000 for mouse fibroblasts [12].  Upto five different 
components  could be observed in adult cbdcken 
liver cytosol [I 8] a i theu~l  only one was present in 
16 day old chick embryo cytosol [19].  Only one of  
these five entities appeared to e.',daibit receptor activity 
as judged by binding to nuclei and the contr ibut ion 
of  others was not clear nor was it assessed whether 
polymerization could explain this multipl icity since 
rechromatography o f  individual peaks was not 
attempted [I 8].  
From the foregoing, techniques used for receptor 
separation based most ly on component  molecular 
weights led inadvertently to the concept o f  a homo-  
~eneous, unitary monomer  capabte o f  polymerisa- 
tion into larger, dissociabte shits. With advance in 
technology of  charge dependent fractionation, 
receptor po lymorphism in vitro could be made evident 
in presence o f  different steroids, ions and resins and 
is summarised below; selected properties have been 
condensed in table !.  
The most detailed analysis wRh DEAE-cellulose- 
52 resins was conducted by the author beginning as 
early as 1970 with rat liver [9--~ 1] and more recentRy 
extended to include a number  o f  other tissues and 
par.".m~iers [20--24] ,  including human liver [25,26].  
It was clearly revealed that all tissues [23,24] appeared 
to possess a GR~ e)3mponent o f  the ~ucoeort icoid-  
specific receptor (GR} eluted in the low ionic prewash 
followed by a GR4 component  coeiuted with blood 
serum transcortin in double-labelled experiments. 
The fact that a GR3 moiety,  in place o f  the GR4 
entity, was observed when synthetic steroids were 
substituted for natural analogues gave rise to the 
speculation that these two groups o f  molecules may 
activate distinct cellular components  and this may 
~xptain greater potency o f  syi~thetic derivatives [22].  
A GR2 component  could be observed only with 
corticosterone and may perform organ specific lunc- 
h:ion in the liver [9--11,15,26] since it was not observed 
in other tissues [23].  independent observations by 
others reveal at least two binding components  for 
most steroid hormones [27].  The im_portance o f  ion 
selection wa; amply demonstrated by the fact that 
10-fo!d greater ionic concentrat ions were required 
for elution o f  the same component  when chloride- 
containing buffers were used in place o f  phosphate 
buffers and even Nag] ver:us KCI did not behave in a 
similar manner [20,21,28,29].  
Certain authors have remonstrated liver receptor 
heterogeneity, on DEAE--Sephadex A-50 columns 
[16] but this has been less successful in our own 
experience with A-50 and A-25 resins [22].  Never- 
thetess, receptor multipl icity was a_rnp!y evident by 
these various techniques despite the suggestion that 
this may imply diversity in cell types, at least in the 
brain [30].  Suggestion has also been forthcoming 
that some o f  the components  separated on phospho- 
cellulose columns may bind steroid metabol ites [3 ~ 
and, in most  studies, one or more entities exhibit 
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Table 1 
Selected physico-chemical properties ofg[uco- and minera!o-ster,~id receptor components 
Janua_ry ~978 
Component Steroid Tissue M phosphate 
specificity distribution etufion region 
DEAE-52 column 
Peak S -R  complex 
conductivity (20°C) 
mili Siemens 
GR~ synthetic > all tested 0.001 M 0.18 
natur~-! 0.2 
GR= corticosterone liver only 0.02 M 5.0 
GR a synthetic only aR tested 0.04 M 5.8 
GR, natur~ ouly all tested 0.06 M 9.2 
MR 18-hydroxydeoxy- kidney 0.001 M 0.2 
corticosterone 
MR= a ldosterone  > k idney ,  0 .006  M 2.3 
t r iameino lone  hear t?  
MR a deoxycortico- kidney 0.06 M 9.2 
sterone 
Transcortin natural serum 0.06 M 9.8 
cor t i co ids  tissue*. 
Albumin all tested plasma 0.06 M 8.9 
Male, adrena~ectomised rats were used throughout in all cases. In most instances, iO -~ M steroid 
concentration was used to detect he receptor component with a 30-40% organ cytoso!. Elution 
molar l t ies  f rom DEAE-cenu lose -52  co lumn were  brought  to  26°C fo r  determ~at ion  o f  the  spec i f i c  
conductivity. This was deemed more accurate than automatic temperature compensation method [51 
due to less variation between experLments (unpublished). For other details ee text and the corre- 
sponding reference 
t ranscor f in l ike  proper t ies  (see be low) .  
A number  o f  agents ( theophy! l ine ,  temperature ,  
ions, so lub le  factors)  act ivate the inert  cy top lasmic  
receptor -s tero id  comple× pr ior  to its a t tachment  
w i th  nuc lear  acceptor  sites. The inact ive fo rm appears  
more  acidic than the act ivated complex  on DEAE- -  
Sephadex  co lumns  [16] and,  in an aqueous  dext ran- -  
po lyethy lene  ~yco l  two  phase sys tem,  act ivat ion  is 
accompan ied  first by  an increase and then a decrease 
in the  par t i t ion  coef f ic ient  o f  the complex  [32] .  
CoRect ivety,  a l though stero id  metabo l i sm does not  
permi t  unequivoca l  appraisal  o f  the  nature  o f  receptor  
in vi.vo, the po lymorpmc complex  ev ident  in v i t ro 
awaits  fur ther  ar.alysis Oia pur i f i cat ion .  
4. Mteera~oeert ico id  receptor  
The unusual ly  labi le nature  o f  minera locor t i co id -  
specif ic receptor  (MR)  makes  it par t i cu lady  d i f f icu l t  
to a t tempt  any sort  o f  phys ica l  separat ion.  In one o f  
the ear l iest  a t tempts ,  chromatography  on Sephadex  
. . . . .  aled a and agarose gels rov~ - s in~e set o f  a !dosterone- -  
specif ic b ind ing sites in toad  b ladder  with tool .  wt  
100 000-200 000 [33] .  Sb'aflar conc lus ions were 
arr ived at using rat k idney  [3 ] .  
By far the most  comprehens ive  analysis o f  renal 
minera lo-  and g luco-cor t ico id  receptors  has beer', 
carr ied out  in the author ' s  laboratory  over the past  
several years.  Rather  than a homogeneous  vector  
[3 ,4 ] ,  a ldosteroue-spec i f ic  b ind ing proteLns cou ld  be 
e luted as MR1 and MR2 units  f rom the DEAE-ceUulose-52 
co lumns;  besides k idney  MR2 was to ta l ly  lacking in all 
o ther  t issues h i ther to  tested inc luding the l iver 
[15 ,34] .  MR:  e lu ted  in the same pos i t ion  as GR,  but  
these cou ld  be d ist inguished wi th  var ious minera lo-  
cor t i co id  agorfists [35] .  Thus,  18-hydroxydeo×y-  
cor t i cos terone  was bound only to MR~ ent i ty  whereas 
deoxycor t i cos terone  was bound both  to MR~ and to 
a MR3 moiety  that  coe lu ted  wi th  b lood  serum trans- 
3 
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cortin (see below). With a synthetic steroid possessing 
bo~h gluco- a~d mineralo- activity, 9~-ftuorocortisol 
preferentially saturated MR in a bifunctional organ 
that is target for both groups of  steroids [36i .  Thus, 
only one subspecies o f  the complex receptor system 
need be saturated for physiological activity and this 
may form an explanation for varying potencies of  
difi~rent mineraiocorticoid agovists. It has not yet 
been possible to test the behaviour o f  an antisteroid 
(spironolactone) under these conditions. 
Fractionation based both on molecular wei~tt and 
charge, on ~phade× A-25 columns, was less informa- 
tive than DE-52 profiles due possibly to high KCI con- 
centrations in the eluting buffer which is known to 
favour dissociation into inonomers o f  comparable 
properties. Thus, with this procedure it was not 
possible to distinguish between differential binding 
of  various mineralocorticoid agonists as described 
above for DE-52. 
Fi l :ration throu~q Sephadex G-200 columns 
reveal .~d a !Jo~,ter peak of  67 000 da!tons preceded by 
a hea~ ier component  of' 113 000 daltons although the 
~etati~e amount  found was a function o f  steroid struc- 
ture [35].  Therefore, atl three atbrement ioned com- 
ponents (MRs, MR, ,  k!Ra) appear to possess closely 
similar molecuiar size with possiblities o f  aggregation 
on Sephadex G-200 as tYequently observed ~-ith 
binders for other steroids. In stilt other studies, only 
the lower molecular weight peak was observed when 
0.4 M KC1 was present during ffactionation on Sephadex 
G-200 lending further support to the possibility Of 
dimerisation under physiological conditions [37].  
These dift~rences were conf irmed by actual con- 
ducti-~ity measurements for both groups of  steroids 
and further support the view that both GR and MR 
are endowed with a polymorphic,  complex,  hetero- 
geneous nature that becomes evident upon physical 
separation and than can not be revealed by satura- 
tion characte~ics  Mone [5].  
5. Ce!inlar 'transcorfin-like" Mnders 
Corticos~eroid-binding globulin (CBG) is a protein 
of  about 63 000 daltons capable of  associating with 
a wide variety o~ steroid hormones [38] .  This high 
capacity, lo~ specificity carrier can  be distinguished 
fron, low capacity, high affinity tissue receptor by 
binding characterstics. However, it is a constant 
source o f  frustration to draw a line between them 
on chromatographic systems due to very close mole- 
cular weights o f  CBG and receptor monomers  and the 
fact that a receptor subspecies may coelute with 
transcortin ha separations based on charge. Indeed, 
there has been a tendency to dismiss as transcortin aU 
that elutes in the same position as C•G-bound steroid 
[39].  This is wrong. 
In our laboratory ,  ordy GP~ and MR3 components  
o f  the g!uco- and the mineralo-receptor, filled with 
natural tritiated hormone,  coeluted w~th CBG-bound 
[14C]steroid from the DE-52 column [37].  Both 
deoxycort icosterone (DOC) and 18-hydroxydeoxy-  
cort icosterone (18-OH-DOC) bind very avidly to 
CBG; yet,  although DOC labelled MR3 in the kidney, 
no DOC-bound radioactivity coeluted with transcortin 
marker when liver cytosol  was used aespite the fact 
teat  this organ is the site of  CBG synthesis. Further- 
• -nore, 18-OH-DOC did not label any protein in 
the CBG region in either the hepatic or the renal 
cytosol  [35].  Althouo~h fluorinated steroids do not  
generally bind to CBG [38],  9a-f luorocorf isol is an 
exception [40].  With this potent steroid, a GR3 
ent i ty could be labelled in the liver in keeping with 
GR~ saturation by other synthetic steroids [22,37].  
However, under otherwise sL-nilar conditions, 9a- 
f luorocorfisol labelled GtL~ (and not GR~) in rat 
myocard ium and this coeluted with [~4C]co~-~i- 
costerone fdled CBG from DE-52 column [40].  
Further arguments to distinguish between trans- 
co~"tin and CBG-like receptors tem from reconsti- 
tut ion experiments. Renal cytosol-bound [3 H]cort i-  
costerone, in presence o f  excess dexamethasone to 
prevent cort icosterone binding to glucoreceptor, 
could be transferred to purif ied nuclei whereas cram 
bound cort icosterone did not transfer, and this was 
conf irmed by au.toradiography [3] .  Furthermore,  
in hypotonic  sucrose gradients both 8 S and 4 S peaks 
o f  bound [3 H]corf icosterone (in presence o f  excess 
dexaethasone) were observed in renal cytosot whereas 
transcorfin showed ordy a 4 S peak. 
These data would argue against he idea that atl 
cellular binders that coelute with CBG are a reflection 
o f  cytosol contaminat ion ~th  circulating transcorfin 
[39].  it is however conceivable that they may repres- 
ent a modif ied form of  transcortin ecessary for phy- 
siological action of  selected steroid agonists. Receptor 
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purif ication is clearly required to answer this unequi- 
vocally. 
6. Fhysio lo~ea| hnp[~cations 
The principal difficulty in analysing "he cyto- 
plasmic receptor system stems from the labile nature 
o f  the vector protein and the fact that the carrier can 
be detected only after it is bound to its steroid ligand. 
Thus, the nature of  the native receptor in cytoplasm 
remains entirely speculative. I f the free cytosol 
receptor is not bound to another stabfiising comp0- 
nent o f  the cell, why does it remain biologically 
active since it is rapidly inactivated in vitro in absence 
of  the specific iigand? To account for these and other 
experimental data, two sorts o f  post-translational 
modif ications have been evoked. First, based on the 
allosteric equil ibrium model o f  Monod et al. [4t]  
stipulates pontaneous transformation of  the low 
affinity form of  the receptor into a high_ aff inity forn.'- 
after the latter is bound to its specific iigand; to date, 
however, no evidence has been forthcoming to sub- 
stantiate the existence of  two sorts o f  receptors. 
Second, ba~ed on the ' induced fit '  concept of  Kosh- 
land et al. [42],  predicts the existence of  only one 
sort o f  cytoplasmic vector whose confommtionat  
modif ication is dictated by the stereospecif icity o f
the corticoid ligand. Both models evade the basic 
problem of  receptor stabil ity in absence o f  steroid 
in vivo. The steroid-bound receptor is supposed to 
undergo an enzymatic activation (temperature-,  ion- 
and soluble factor-dependent) leading to the appear- 
ance o f  positively charged groups (hence binding to 
phosphoceHulose) while conserving the negatively 
charged regions that endow it with the ability to bind 
to DEAE prior to activation [~9].  All these studies 
favour ~ome sort o f  maturat ion of  a more prel iminary 
entity whose nature in situ remains unknown. 
There is no general consensus on the manner in 
wNch the s tero id - receptor  complex of  varying 
molecular weights penetrates the nuclear membrane 
which presents a barrier to macromolecules of
:> 70 000 daltons. Once in the rmcleop!asm, steroid-- 
receptor complex is reported to interact with the 
acceptor. The acceptor is a concept and not an experi- 
mental ly demonstrated fact although in the case o f  
the estrogens specificity with respect o the source of  
nuclei is in favor o f  its existence. Thus, binding is 
possible with DNA, the acidic or the basic proteins, 
or even RNA po!ymerase [ 1 --5 ].  This is further com- 
plicated by the presence of  possibly only a few high 
affinity sites and a very large number o f  low aff inity 
sites in the nucleus [43],  as in the case of lac  operon 
[44].  Somewhat in contrast o these is the suggestioi~ 
that g iucocort ico id-receptor  complex binds more 
readily to naked DNA than to native DNA [29].  Thus, 
a positive control  o f  nuclear proteins in increash~g 
progesterone-receptor  binding (and thereby response) 
to chick oviduct genome [45] is to be weighed against 
a negative control o f  these proteins in deereasir~g such 
response in th~ liver glucocorticoid model [29].  
The above mentioned sequence of  events was 
based on the assumption of  a single class o f  cytoplas- 
mic receptor protein endowed with oi~e binding site. 
How can this be acccmodated in terms of  multiple 
molecular fomls of  GR and MR sununarised in the 
preceding sections as well as s~Smilar sort o f  muLtipli- 
city reported for estrogen [45] ,  androgen [46] and 
progesterone [47] receptors? 
Thus, a second alternative would consist o f  differ- 
ent proteins each capable of  binding to any one given 
steroid. This is difficult to visualise since an animal 
does not come in contact with synthetic steroids 
either during ontogeny or phylogeny, since cross 
reactivity is observed between cortisoi and dexa- 
methasone binders [31 ] ,  and since redundancy in 
control  at this level would call for several genes regu- 
lating the formation of  various receptor proteins 
although a sin~e mutat ion in receptor function is 
known to deplete cellular receptor for all classes of  
glucocorticoids in vitro [43 ]. 
Consequently, one is left with the alternative of a 
complex protein with different binding sites. This is 
not only consistent with receptor maturat ion men- 
t ioned above but is also supported by stereochemicai 
considerations o f  steroid versus protein structure and 
has some experimental basis [48].  Conformation 
(total geometric disposition in three dimensions) is 
dictated by the pffmary structure of  the protein and 
can not be altered in the final pro&act. Similarly, con- 
figuration and conformat ion o f  a steroid molecule 
are not expected to adjust to requirements necessitated 
by the receptor protein. Rather, A-ring orientation 
may dictate potency o f  glucocorticoid activity in the 
9c~-halogenated derivatives of  cortiso! [49].  With 
mineralocorticoids, the relative in vivo potency 
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9~x-fluorocortisot > aldosterone > DOC > 18-OH-DOC 
is based  on  subst i tu t ions  in  w ide ly  d i f fe rent  pos i t ions  
of  the steroid molecule. Since the A-ring orientation 
of  these derivatives may be quite similar in X-ray 
crystal lography [49],  requirement tbr activity may 
reside in other, very dissimilar spatial orientations 
reco~-iisable only by different, corresponding confor- 
mations of  the receptor. 
7. "i--tte muitipo[ac model 
Bearing in mind all these diverse experimental 
observations, and some hypothetical  incertitudes, one 
can visualise the fo iovdng sequence of  events. The 
native v~otem is probably a very. complex, uncom- 
Fni¢ted entity that may be called a Proreceptor. In 
presence of- in active agonist o f  l-~igah potency and 
affinity, differentiatio~n leads to an active confor- 
mation which differs from that obtained in presence 
o f  a weak synergist. Stability of  the proreceptor 
may be  assured  i f  one  we re to  assume that  it remains  
bound to the ribosome until an appropriate steroid 
ligand were to come by for complexing. Post trans- 
_ J~_ .  
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cr:iptionM modif ication o f  tRNA,  Hn. RNA, and post 
translationM cleavage o f  low molecdlar weight pro- 
te~.has from a larger precursor, are z..li well established 
rel~latoD" mechanisms. Indeed, p~,;tease activation 
o f  a number  o f  systems, inc!udhag tha~ of  the 
receptor [48] ,  is an experkmentaly  observed fact. 
Fo l low ing  d i f fe rent ia t ion ,  the  ]qascent  Receptor  
would undergo a temperature-,  ion- and prestimeMy 
enzyme-dependent maturat ion into an active Ho[o- 
receptor capable o f  interacting wi.~ah nuclear acceptor 
sites. Depm~d~ng upon its chemical nature, an antag- 
onL~t may either "freeze" the proreceptor,  thereby 
inhibiting .~nteraction with active steroids in the open 
sites and further differentiation, or provoke an inactive 
conformat ion by ac~.ualy frilling the bmdkng region 
thereby e~iminating maturat ion.  In the active confor- 
mation,  besides the major forearm carrying the 
steroid for interaction with high affinity sites in DNA, 
the other antennae o f  the receptor would possess 
unfilled sites (hatched) with potential for association 
wffh other steroids o f  high affinity and for binding to 
chromat in  in  low af f fmity reg ions  thereby  exer t ing  a 
podtive [43] or a negative [29] modulat ion in host 
genome (see fig. t for schematic representation). 
~-- ~ ' - - i ]  ]~ maturat ion  
T°/ l+j F~ 
4/  
NASCENT RECEPTOR 
( inactive ) 
~ [  nil 
S> 





g ~, X 
HOLORECEPTOR 
(ac t ive)  
-~ N IL  
Fig. i .  MULTIPOLAR MODEL OF R~--CEPTOR TRANSFORMATION 
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[n th~ mode~ ample provision has been made to 
account for the observed subspecies (GR~, GR2, GRa, 
GR4 or MR1, MR2, MR3} that may also be construed 
as subunits observed in hypo- and hypertonic media. 
Can, in a bifunetional organ like the kidney, the pro- 
receptor differentiate into either GR or MR, since this 
would entail great economy in cellular information 
transfer and since most gluco- and mineralo-cor~'coids 
overlap their respective domains o f  action? This must 
await receptor purification. The possibility may also 
be entertained where transcortin could form a part of  
the complex receptor system by cleavage and repair 
type of  mecl-anism known for DNA. 
8. Conctudi~g speeulatiorm 
[t can not be emphasized enough that a receptor 
can only be detected when bound to its steroid ligand 
and that the nature o f  native, uncommitted vector in 
cell cytoplasm is still unknown. Conceptual and tech- 
mcal considerations favoured propagation of  receptor 
models where all agonists and antagonists of  a steroid 
were supposed to interact with varying affinities to 
the same carrier in keeping with the view of  one 
protein--one binding site. More detailed physico- 
chemical anMysis reveMed multiple molecular forms 
o f  the receptor for all five groups of  steroids, along 
with preferential increases or decreases in qualitative 
abundam_ce of  some of  these species during differentia° 
finn [ 19,50] and in rat liver where physiological 
response to ~ueocorticoids b_ad been modi~ed by 
prior treatment with either carbon tetrach!oride o"
bacterial endotoxin [ 17,51,52]. At a purely specu- 
lative level, too, it became necessary to postulate 
some sort o f  redundancy i_n mechanisms required to 
disc_ri_minate signal from noise given the fact o f  multi- 
plicity of  circulating agonists as well as some cross 
reactivity in physiological effects (viz., gluco- versus 
minera!o-). Bifunctional organs (kidney) further 
demand consideration of  control at levels not too far 
removed in  phys io log ica l1  h ie rarchy .  The  M, -d t ipo la r  
model presented here accomodates these various 
facets and calls for binding to beth low and high 
affinity regions in the rather hypothetical cceptors 
in the nucleus. Steroids with antagonist activity are 
expected to provide further leads in this respect ~nd 
some such work is in progress [53,54].  Fina2~y, indul- 
gence is asked o f  MI those researchers who moved 
away from receptor characterisation as a futile exercise 
and who hold that the key to the specificity of  steroid 
action ties within the nucleus. Certai~ ricks ere weU 
worth taking to look for unity in the midst o f  apparent 
diversity. 
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